175 related articles for article (PubMed ID: 34493476)
21. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
22. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
23. Trends of Incidence and Survival Rates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database.
Jeong SH; Hyun SY; Choi JS; Kim HM
J Korean Med Sci; 2020 Sep; 35(36):e294. PubMed ID: 32924338
[TBL] [Abstract][Full Text] [Related]
24. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M; Ross CW; Hsi ED
Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
[TBL] [Abstract][Full Text] [Related]
26. Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma.
Amiot A; Jooste V; Gagniere C; Lévy M; Copie-Bergman C; Dupuis J; Le Baleur Y; Belhadj K; Sobhani I; Haioun C; Bouvier AM; Delchier JC
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140708
[TBL] [Abstract][Full Text] [Related]
27. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour.
Wenzel C; Dieckmann K; Fiebiger W; Mannhalter C; Chott A; Raderer M
Leuk Lymphoma; 2001 Aug; 42(4):823-9. PubMed ID: 11697516
[TBL] [Abstract][Full Text] [Related]
28. Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases.
Bates AW; Norton AJ; Baithun SI
J Clin Pathol; 2000 Jun; 53(6):458-61. PubMed ID: 10911804
[TBL] [Abstract][Full Text] [Related]
29. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
30. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
[TBL] [Abstract][Full Text] [Related]
31. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features.
Yoshino T; Omonishi K; Kobayashi K; Mannami T; Okada H; Mizuno M; Yamadori I; Kondo E; Akagi T
J Clin Pathol; 2000 Mar; 53(3):187-90. PubMed ID: 10823136
[TBL] [Abstract][Full Text] [Related]
33. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
34. Second Primary Malignancies in Adults with Gastric Cancer - A US Population-Based Study.
Shah BK; Khanal A; Hewett Y
Front Oncol; 2016; 6():82. PubMed ID: 27148474
[TBL] [Abstract][Full Text] [Related]
35. Classification of primary gastric lymphomas according to histologic features.
Hsi ED; Eisbruch A; Greenson JK; Singleton TP; Ross CW; Schnitzer B
Am J Surg Pathol; 1998 Jan; 22(1):17-27. PubMed ID: 9422312
[TBL] [Abstract][Full Text] [Related]
36. Recent developments in our understanding of gastric lymphomas.
Isaacson PG
Am J Surg Pathol; 1996; 20 Suppl 1():S1-7. PubMed ID: 8694145
[TBL] [Abstract][Full Text] [Related]
37. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
38. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
39. Clinical aspects of malt lymphomas.
Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Kyriakaki S; Yiakoumis X; Sachanas S; Moschogiannis M; Tsirkinidis P; Korkolopoulou P; Papadaki HA; Angelopoulou MK
Curr Hematol Malig Rep; 2014 Sep; 9(3):262-72. PubMed ID: 25240474
[TBL] [Abstract][Full Text] [Related]
40. Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.
Bacon CM; Du MQ; Dogan A
J Clin Pathol; 2007 Apr; 60(4):361-72. PubMed ID: 16950858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]